Australia's Lumos Diagnostics set for best day in 8-1/2 months on US contract win

Lumos Diagnostics Holdings

25/09/2024 04:21

** Shares of Lumos Diagnostics Holdings  LDX.AX  rise as
much as 23.4% to A$0.042, set for best day since Jan. 11 - if
current gains hold  
    ** Medical equipment manufacturer announces placement of its
respiratory test FebriDx on the U.S. MediGroup national contract
    ** Says MediGroup is single largest non-acute care group
purchasing organisaton, which oversees equipment procurement for
healthcare providers
    ** FebriDx evaluates respiratory infection in a patient
during emergency care
    ** Shares hit highest level since Sept 9 
    ** LDX down 44.5% YTD, including day's moves 

 (Reporting by Nikita Maria Jino in Bengaluru)
 ((Nikita.Jino@thomsonreuters.com;))